Challenges in harmonizing integrated healthcare network laboratories: Multi-center evaluation of the AccuTnI+3 troponin assay

Clinical Biochemistry

Volumn 48, Issue 4-5, 2015, Pages 268-274

  Greene, Dina N ^a   Holmes, Daniel T ^b   Liang, Joy ^a   Kwong, Shiu Land ^a   Lorey, Thomas S ^a   Petrie, Matthew S ^a  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

AccuTnI+3; Beckman Access; Harmonization; TnI; Troponin I; Validation

Indexed keywords

REAGENT; TROPONIN; TROPONIN I; BIOLOGICAL MARKER;

ACCUTNI+3 TROPONIN ASSAY; ACUTE HEART INFARCTION; ARTICLE; BLOOD SAMPLING; CALIBRATION; CARDIAC TROPONIN 1 CLIA; CARDIAC TROPONIN 1 CLIA KIT; CHEMICAL PARAMETERS; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HEALTH CARE; HOSPITAL LABORATORY; HUMAN; IMMUNOASSAY; INTERRATER RELIABILITY; LABORATORY TEST; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIMIT OF THE BLANK; MULTICENTER STUDY; PLASMA; PREDICTIVE VALUE; PRIORITY JOURNAL; SERUM; BIOASSAY; BLOOD; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; EVALUATION STUDY; INTEGRATED HEALTH CARE SYSTEM; PROCEDURES; STANDARDS;

BIOLOGICAL ASSAY; BIOMARKERS; CLINICAL LABORATORY TECHNIQUES; DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; LIMIT OF DETECTION; TROPONIN I;

EID: 84924605276     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.11.009     Document Type: Article

References (20)

1. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012, 60:1581-1598.
2. Sandoval Y., Apple F.S. The global need to define normality: the 99th percentile value of cardiac troponin. Clin Chem 2014, 60:455-462.
3. Cullen L., Parsonage W.A., Greenslade J., Lamanna A., Hammett C.J., Than M., et al. Delta troponin for the early diagnosis of AMI in emergency patients with chest pain. Int J Cardiol 2013, 168:2602-2608.
4. Apple F.S., Smith S.W., Pearce L.A., Murakami M.M. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the advia centaur TnI-Ultra assay. Clin Biochem 2012, 45:711-713.
5. Reichlin T., Irfan A., Twerenbold R., Reiter M., Hochholzer W., Burkhalter H., et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011, 124:136-145.
6. Apple F.S., Collinson P.O. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012, 58:54-61.
7. Clinical and Laboratory Standards Institute Evaluation of precision performance of quantitative measurement methods. CLSI document 2004, EP05. CLSI, Wayne, PA USA. 2nd Ed.
8. Clinical and Laboratory Standards Institute Protocols for determination of limits of detection and limits of quantitation. CLSI document 2004, EP17. CLSI, Wayne, PA USA.
9. Armbruster D.A., Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev / Aust Assoc Clin Biochem 2008, 29(Suppl. 1):S49-S52.
10. Wu A.H., Shea E., Lu Q.T., Minyard J., Bui K., Hsu J.C., et al. Short- and long-term cardiac troponin I analyte stability in plasma and serum from healthy volunteers by use of an ultrasensitive, single-molecule counting assay. Clin Chem 2009, 55:2057-2059.
11. Kavsak P.A., MacRae A.R., Yerna M.J., Jaffe A.S. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury 2009, 55:573-577.
12. Uettwiller-Geiger D., Wu A.H., Apple F.S., Jevans A.W., Venge P., Olson M.D., et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002, 48:869-876.
13. Basit M., Bakshi N., Hashem M., Allebban Z., Lawson N., Rosman H.S., et al. The effect of freezing and long-term storage on the stability of cardiac troponin T. Am J Clin Pathol 2007, 128:164-167.
14. Agarwal S.K., Avery C.L., Ballantyne C.M., Catellier D., Nambi V., Saunders J., et al. Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin Chem 2011, 57:891.
15. Peake R.W., Deans K.A., Croal B.L. A practical assessment of the short-term in vitro stability of troponin I at the 99th percentile. Ann Clin Biochem 2011, 48:377-379.
16. Apple F.S., Murakami M.M., Christenson R.H., Campbell J.L., Miller C.J., Hock K.G., et al. Analytical performance of the i-STAT cardiac troponin I assay. Clin Chim Acta 2004, 345:123-127.
17. Pretorius C.J., Dimeski G., O'Rourke P.K., Marquart L., Tyack S.A., Wilgen U., et al. Outliers as a cause of false cardiac troponin results: investigating the robustness of 4 contemporary assays. Clin Chem 2011, 57:710-718.
18. Fleming S.M., O'Byrne L., Finn J., Grimes H., Daly K.M. False-positive cardiac troponin I in a routine clinical population. Am J Cardiol 2002, 89:1212-1215.
19. Wu A.H., Jaffe A.S., Apple F.S., Jesse R.L., Francis G.L., Morrow D.A., et al. National academy of clinical biochemistry laboratory medicine practice guidelines: use of cardiac troponin and b-type natriuretic peptide or n-terminal prob-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007, 53:2086-2096.
20. Storrow A.B., Christenson R.H., Nowak R.M., Diercks D.B., Singer AJ W.U.A.H.B., et al. Diagnostic performance of cardiac troponin I for early rule-in and rule-out of acute myocardial infarction: results of a prospective multicenter trial. Clin Biochem 2015, 48:252-257.